Global High-Priority Regulatory Events — January 27, 2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

28-01-2026

Hecla Mining Co/DE/ filed a Form 8-K on 2026-01-28 reporting entry into a Material Definitive Agreement under Item 1.01, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing with no specific details, transaction values, financial metrics, or period-over-period comparisons disclosed in the provided information. No quantitative impacts, positive or negative metrics, or strategic context are available.

28-01-2026

28-01-2026

Zeo ScientifiX, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's identity, position, reason for change, timing, or compensatory arrangements are disclosed.

28-01-2026

Luminar Technologies, Inc./DE filed an 8-K on 2026-01-28 reporting entry into a Material Definitive Agreement under Item 1.01 and Financial Statements and Exhibits under Item 9.01. No quantitative metrics, period-over-period comparisons, transaction values, financial impacts, or specific agreement details are disclosed in the provided filing information. This is a multi-item mandatory disclosure for material events, but core terms and implications remain NOT_DISCLOSED.

28-01-2026

Horizon Space Acquisition I Corp. filed an 8-K on 2026-01-28 (AccNo: 0001929980-26-000025, Size: 178 KB) disclosing changes in its certifying accountant under Item 4.01. Item 9.01 references financial statements and exhibits. No merger/acquisition details, quantitative metrics, period-over-period comparisons, or other financial data are explicitly stated in the filing summary.

28-01-2026

Plum Acquisition Corp, IV filed an 8-K on 2026-01-28 disclosing information under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific deal structure, parties, valuation, financial terms, synergies, regulatory pathway, or shareholder impacts are disclosed in the provided filing information. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.

28-01-2026

Marine Products Corp filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.

28-01-2026

RPC Inc filed an 8-K on January 28, 2026 (AccNo: 0001104659-26-007185), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any financial metrics are disclosed. Filing size: 167 KB; sector NOT_DISCLOSED.

28-01-2026

Hindustan Petroleum Corporation Ltd (BSE: 500104) issued a rumour verification under Regulation 30(11) of SEBI (LODR) on January 28, 2026, providing clarification or confirmation on a news item appearing in media or publication. No details on the specific rumour, its verification status (confirmed/denied/noted), or any associated corporate actions, financial metrics, or impacts are disclosed. Sector is not specified.

28-01-2026

Ultra Clean Holdings, Inc. filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data are provided in the filing summary.

28-01-2026

Capstone Holding Corp. filed an 8-K on January 28, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing focused on voluntary dissemination of potentially material information compliant with Regulation FD, with exhibits attached. No specific financial metrics, transactions, positive or negative changes, guidance, or quantitative data are disclosed in the provided filing summary.

28-01-2026

ALT5 Sigma Corp filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, or any quantitative metrics provided.

28-01-2026

Pacira BioSciences, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including officer names, positions affected, appointment or resignation status, reasons, and any financial metrics are NOT_DISCLOSED.

28-01-2026

AiXin Life International, Inc. filed an 8-K on 2026-01-28 (AccNo: 0001493152-26-003883, Size: 226 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for change, or quantitative data are disclosed.

• ·Sector: sector not specified

28-01-2026

Ellington Financial Inc. filed an 8-K on 2026-01-28 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits attached under Item 9.01. No specific details on the agreement's nature, parties, dollar value, financial impacts, or performance metrics (positive, negative, or flat) are disclosed. This is an informational filing without quantified revenue, earnings, balance sheet effects, or guidance changes.

• ·Filing Accession Number: 0001628280-26-003722
• ·Filing size: 542 KB

28-01-2026

Community Trust Bancorp Inc /KY/ filed a Form 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 9.01 financial statements and exhibits. No specific details including transaction values, personnel names, dollar amounts, financial impacts, or exhibit contents are disclosed in the provided filing information.

28-01-2026

Burke & Herbert Financial Services Corp. filed an 8-K on January 28, 2026 (AccNo: 0001964333-26-000008), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for the change, timing, or any quantitative financial metrics are disclosed.

• ·Filing size: 167 KB

28-01-2026

28-01-2026

US Bancorp (DE) filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or impacts were disclosed.

28-01-2026

El Pollo Loco Holdings, Inc. filed an 8-K on January 28, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details such as the key position affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed in the provided filing summary. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

• ·AccNo: 0001104659-26-007246
• ·Filing size: 206 KB
• ·Event date: January 28, 2026
• ·Sector: sector not specified

28-01-2026

Perma-Fix Environmental Services Inc. filed an 8-K on January 28, 2026 (AccNo: 0001493152-26-003909), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on individuals affected, nature of changes, reasons, or effective dates are disclosed in the filing summary.

28-01-2026

FIRST COMMONWEALTH FINANCIAL CORP /PA/ filed an 8-K on 2026-01-28 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific details on officer identities, positions affected, reasons for change, financial metrics, or performance comparisons are disclosed. No quantitative data, scheduled events, or forward-looking statements are mentioned.

28-01-2026

Healthcare Triangle, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001213900-26-008594), disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also reports unregistered sales of equity securities (Item 3.02) and Regulation FD disclosure (Item 7.01), with financial statements and exhibits (Item 9.01). No quantitative metrics, deal values, parties, or financial impacts are disclosed.

28-01-2026

ATLANTIC INTERNATIONAL CORP. filed an 8-K on January 28, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.01 completion of an acquisition or disposition of assets. The filing also covers Item 2.03 creation of a direct financial obligation, Item 3.02 unregistered sales of equity securities, Item 5.02 changes in directors or officers including compensatory arrangements, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific transaction parties, deal size, financial metrics, synergies, or impacts are disclosed.

28-01-2026

LOUISIANA-PACIFIC CORP filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details such as the affected position (e.g., CEO, CFO), appointment or resignation status, reasons for change, or any quantitative financial metrics are provided. Filing size is 653 KB with no performance data, positive or negative metrics, or period-over-period comparisons mentioned.

28-01-2026

Highland Opportunities & Income Fund filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.03 covers amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits; no specific names, reasons, financial impacts, or quantitative details are provided.

28-01-2026

Highland Global Allocation Fund filed an 8-K on January 28, 2026, disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also reports under Item 5.03 amendments to articles of incorporation or bylaws, or a change in fiscal year, and under Item 9.01 includes financial statements and exhibits. No specific names, reasons for changes, quantitative impacts, or other details are disclosed.

28-01-2026

Progressive Corp/OH/ filed an 8-K on January 28, 2026 (AccNo: 0000080661-26-000071, Size: 624 KB), disclosing results of operations and financial condition under Item 2.02, an officer change, departure, election, appointment, or compensatory arrangements under Item 5.02, and financial statements/exhibits under Item 9.01. Specific details on the officer position, name, reason for change, financial metrics, or performance comparisons are NOT_DISCLOSED. No quantitative data, scheduled events, or governance implications are provided in the filing summary.

28-01-2026

28-01-2026

Schneider National, Inc. filed an 8-K on January 28, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the affected officer, position, reason for change, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

28-01-2026

Workiva Inc filed an 8-K on 2026-01-28 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individuals involved, reasons for the change, or any financial metrics are disclosed in the provided information. No positive or negative performance metrics are mentioned.

28-01-2026

Tempest Therapeutics, Inc. filed a Form 8-K on January 28, 2026, disclosing under Item 3.03 material modifications to rights of security holders, under Item 5.02 departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, and under Item 5.07 submission of matters to a vote of security holders. This is a multi-item mandatory filing with no quantitative financial metrics, transaction values, or specific details provided.

28-01-2026

BITMINE IMMERSION TECHNOLOGIES, INC. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, with exhibits under Item 9.01. This is a multi-item mandatory filing with no details provided on the agreement, personnel involved, financial terms, or impacts. No quantitative metrics, names, or further context are disclosed.

28-01-2026

Ocean Power Technologies, Inc. filed an 8-K on 2026-01-28 disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 5.07 on submission of matters to a vote of security holders and Item 9.01 for financial statements and exhibits. No specific details on affected positions, names, reasons for changes, vote outcomes, or any quantitative metrics are disclosed.

28-01-2026

Ribbon Acquisition Corp. filed an 8-K on 2026-01-28 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year under Item 5.03. Item 9.01 lists financial statements and exhibits. No additional details on the nature of amendments, any merger/acquisition, financial metrics, or sector provided.

28-01-2026

ARCBEST CORP /DE/ filed an 8-K on January 28, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any financial metrics are disclosed. No quantitative data, performance comparisons, or scheduled events are mentioned.

28-01-2026

Belden Inc. filed an 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, strategic context, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

28-01-2026

SenesTech, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001628280-26-003828), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions (e.g., CEO, CFO), individuals involved, reasons for the change (e.g., retirement, performance), timing, or any quantitative financial terms are provided in the filing summary. No positive or negative metrics, performance comparisons, or governance impacts are mentioned.

• ·Filing size: 142 KB
• ·Sector: not specified

28-01-2026

Edgemode, Inc. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and departures or appointments of directors/officers or compensatory arrangements under Item 5.02, with financial statements and exhibits under Item 9.01. No specific transaction values, share counts, financial impacts, or named parties were disclosed. This multi-item filing provides limited details on the events.

28-01-2026

Valley National Bancorp filed a Form 8-K on 2026-01-28 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, timing, or any quantitative metrics are provided. This is a standard governance disclosure without additional context on implications.

28-01-2026

Sonoma Pharmaceuticals, Inc. filed an 8-K on January 28, 2026 (AccNo: 0001683168-26-000589, Size: 287 KB), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

28-01-2026

Tesla, Inc. filed an 8-K on January 28, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely related to quarterly or annual earnings disclosure with attached financial materials. No specific revenue, earnings, guidance, period-over-period changes, positive or negative metrics, transactions, or scheduled events are explicitly stated or quantified in the provided filing details.

28-01-2026

Jabil Inc filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). Specific details including the affected position, whether it is an appointment or resignation, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

28-01-2026

Leonardo DRS, Inc. filed a multi-item Form 8-K on January 28, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03). Item 9.01 includes financial statements and exhibits. No transaction values, financial impacts, or strategic details are disclosed.

28-01-2026

KB Home filed an 8-K on January 28, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 covers financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

28-01-2026

Aeries Technology, Inc. filed an 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's nature, parties, terms, transaction value, financial impacts, or any quantitative metrics are disclosed. No positive or negative performance metrics, guidance changes, or risks are mentioned.

28-01-2026

TON Strategy Co filed an 8-K on January 28, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

28-01-2026

Pasithea Therapeutics Corp. filed an 8-K on January 28, 2026, disclosing under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements; under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year; and under Item 5.07 submission of matters to a vote of security holders. No specific details on affected positions, individuals involved, reasons for changes, voting outcomes, amendment contents, or any quantitative metrics are disclosed.

28-01-2026

V F CORP filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics are mentioned.

28-01-2026

CIMG Inc. filed a Form 8-K on January 28, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. Item 7.01 discloses Regulation FD information, and Item 9.01 lists financial statements and exhibits. No specific financial metrics, transaction values, or additional details such as reasons for delisting, dollar impacts, or market transfer destination were provided.

28-01-2026

Cingulate Inc. filed an 8-K on January 28, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, and amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, with exhibits under Item 9.01. This is a multi-item filing with no specific details on transaction terms, values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are disclosed.

28-01-2026

Inuvo, Inc. filed a Form 8-K on January 28, 2026, as a multi-item disclosure covering Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, financial metrics, executive names, dollar values, percentages, or outcomes are disclosed in the provided filing summary. This appears to be a mandatory multi-item filing combining agreement updates, financial results, and personnel changes.

28-01-2026

Accenture plc filed an 8-K on 2026-01-28 disclosing under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 5.07 covers submission of matters to a vote of security holders, while Item 9.01 references financial statements and exhibits. No specific details on personnel changes, voting results, or quantitative metrics are provided in the filing summary.

28-01-2026

Antero Resources Corp filed a Form 8-K on January 28, 2026 (AccNo: 0001104659-26-007438), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, strategic context, or financial metrics are provided in the filing summary.

28-01-2026

MSCI Inc. filed an 8-K on January 28, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing focused on a material event.

28-01-2026

Armour Residential REIT, Inc. filed an 8-K on January 28, 2026, disclosing under Item 1.01 its entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, financial impacts, or strategic rationale are provided. No quantitative metrics, period-over-period comparisons, or other performance data are disclosed.

28-01-2026

Kohl's Corp filed an 8-K on 2026-01-28 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, names, reasons for change, effective dates, or any quantitative metrics are disclosed.

28-01-2026

Navan, Inc. filed an 8-K on January 28, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, timing, or compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the filing summary.

28-01-2026

Columbus Acquisition Corp/Cayman Islands filed an 8-K on 2026-01-28 (AccNo: 0001213900-26-008893) under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No deal structure details, financial metrics, parties involved beyond the filer, valuations, synergies, regulatory pathways, or shareholder impacts were explicitly disclosed in the filing summary provided.

28-01-2026

Limoneira CO filed an 8-K on January 28, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, reasons, timing, or any quantitative metrics are disclosed.

28-01-2026

Aemetis, Inc. filed a Form 8-K on 2026-01-28 disclosing entry into a material definitive agreement under Item 1.01, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02, and other events under Item 8.01. This is a multi-item filing with no specific transaction details, personnel names, dollar values, financial impacts, or quantitative metrics provided. No positive or negative performance metrics are mentioned.

28-01-2026

Apollo Commercial Real Estate Finance, Inc. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction size, or financial impacts provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

28-01-2026

LIVEPERSON INC filed an 8-K on 2026-01-28 disclosing an Item 5.02 event related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on affected positions, names, reasons for changes, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics, financial data, or further context on the leadership change implications are disclosed.

28-01-2026

COLONY BANKCORP INC filed an 8-K on 2026-01-28 (AccNo: 0000711669-26-000004) reporting results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. Specific details on the leadership change—including position affected, name, appointment/resignation status, reason, or timing—are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are disclosed in the provided filing information.

28-01-2026

Lifeward Ltd. filed an 8-K on 2026-01-28 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and submission of matters to a vote of security holders under Item 5.07. Specific details including key position affected, appointment or resignation status, reasons for change, names, and timing are NOT_DISCLOSED. No quantitative data, financial metrics, period-over-period comparisons, or scheduled events are mentioned.

28-01-2026

Super League Enterprise, Inc. filed a Form 8-K on January 28, 2026, reporting Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the modifications, amendments, or exhibits provided. No financial metrics, positive or negative changes, or quantified impacts are disclosed.

28-01-2026

Repare Therapeutics Inc. filed an 8-K on January 28, 2026, announcing the completion of an acquisition or disposition of assets (Item 2.01), changes in control of the registrant (Item 5.01), and changes in directors or officers including compensatory arrangements (Item 5.02). However, the filing also discloses notice of delisting or failure to satisfy listing standards (Item 3.01) and material modifications to rights of security holders (Item 3.03), alongside other events (Item 8.01) and financial statements/exhibits (Item 9.01). These items indicate a transformative transaction resulting in delisting and altered shareholder rights.

28-01-2026

International Media Acquisition Corp. filed an 8-K on 2026-01-28 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on deal structure, parties, valuation, terms, or financial metrics are disclosed. Sector is not specified.

28-01-2026

ArrowMark Financial Corp. filed a Form 8-K on 2026-01-28 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, positive or negative changes, or performance comparisons are disclosed in the provided filing summary. This is a multi-item informational filing with no specified sector impacts.

• ·AccNo: 0001999371-26-001905
• ·File Size: 3 MB
• ·Multi-item 8-K filing (Items 1.01, 8.01, 9.01)

28-01-2026

Enveric Biosciences, Inc. filed an 8-K on January 28, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, which may imply dilutive financing but lacks specific details. Item 9.01 includes financial statements and exhibits. No quantitative transaction values, share counts, or financial impacts are disclosed.

28-01-2026

Ryman Hospitality Properties, Inc. filed an 8-K on January 28, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreements, transaction values, financial impacts, or other metrics are provided in the filing summary. This multi-item filing reports material events without quantified positive or negative metrics.

28-01-2026

FTAI Aviation Ltd. filed an 8-K on 2026-01-28 (AccNo: 0001140361-26-002691, Size: 215 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names, reasons for changes, timing, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics are mentioned.

28-01-2026

Zoned Properties, Inc. filed an 8-K on January 28, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and under Item 8.01 for other events. No specific details such as affected positions, names, reasons for change, or timing are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.

28-01-2026

Assurant, Inc. filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals, positions, reasons, or financial impacts are disclosed.

28-01-2026

Bluerock Acquisition Corp. filed an 8-K on January 28, 2026 (AccNo: 0001213900-26-008946), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or strategic rationale are provided in the filing summary. Sector is not specified, and no quantitative metrics, comparisons, or scheduled events are mentioned.

28-01-2026

Altimmune, Inc. filed an 8-K on 2026-01-28 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, financial impacts, or strategic rationale are provided. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.

28-01-2026

DIAMOND HILL INVESTMENT GROUP INC filed an 8-K on 2026-01-28 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are provided.

28-01-2026

EGH Acquisition Corp. filed an 8-K on January 28, 2026 (AccNo: 0001104659-26-007494, Size: 331 KB) disclosing information under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, regulatory pathways, or shareholder impacts are explicitly stated in the provided filing information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.

• ·AccNo: 0001104659-26-007494
• ·Filing date: 2026-01-28
• ·Sector: not specified

28-01-2026

OIL STATES INTERNATIONAL, INC filed a Form 8-K on 2026-01-28 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, financial obligation, dollar values, strategic importance, or market impacts disclosed in the provided information. No quantitative metrics, period-over-period comparisons, guidance changes, or scheduled events are mentioned.